Skip to content

low dose nebulized epinephrine in the croup

The effect and safety of low dose nebulized epinephrine in the Treatment of croup

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0002318
Enrollment
84
Registered
2017-05-10
Start date
2016-01-24
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : ED patients with croup - between 6 month and 5 years old - Westley croup score between 3 and 11 Test group is low dose epinephrine (0.1 mg/kg 1:1,000 L-epinephrine) Control group is convent

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Croup Pts c Westley croup score 3-11

Exclusion criteria

Exclusion criteria: under 6mo, over 5yr-old previously enrolled patients participants in another study patients with past history of endotracheal intubation or apnea patients with underlying lung or heart disease patients with contraindication of dexamethasone preterm birth under IUP 36wk patients taking immunosuppressants or immunocompromized patients patients taking steroid within 14 days

Design outcomes

Primary

MeasureTime frame
Westley croup score before nebulized epi and after 30min

Secondary

MeasureTime frame
additional epinephrine nebulized treatment;the side effect of epinephrine

Countries

Korea, Republic of

Contacts

Public ContactJIN HEE LEE

Seoul National University Bundang Hospital

gienee74@gmali.com+82-31-787-7586

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 3, 2026